The review found no eligible studies for this question.
Probiotics showed no clear difference in clinical relapse (52 weeks) compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (low certainty).
Probiotics showed no clear difference in maintenance of clinical remission (52 weeks) compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (low certainty).
It is very uncertain whether probiotics changes serious adverse events (52 weeks) compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
It is very uncertain whether nasogastric changes mortality compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes organ failure (single or multiple) compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes rate of infection (local or systemic) compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes success rate of the procedure compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes complications associated with the procedure compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes surgical intervention compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes requirement for parenteral nutrition compared with nasojejunal tube feeding (very low certainty).
Electroacupuncture showed no clear difference in withdrawal due to adverse events compared with sham electroacupuncture (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.